# Adaptive Radiation in Anal Cancer

> **NCT05838391** · NA · RECRUITING · sponsor: **Columbia University** · enrollment: 20 (estimated)

## Conditions studied

- Anal Squamous Cell Carcinoma

## Interventions

- **RADIATION:** Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery
- **DRUG:** Mitomycin-C
- **DRUG:** 5-Fluorouracil
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT05838391
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05838391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05838391, "Adaptive Radiation in Anal Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05838391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*